APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy GMP Manufacturing Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell Therapy GMP Manufacturing Platform Market Outlook and Growth Opportunities 2026

28 December 2025199 pages

Choose your research edition.

Industry ResearchCell Therapy GMP Manufacturing Platform Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy GMP Manufacturing Platform Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cell Therapy GMP Manufacturing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy GMP Manufacturing Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy GMP Manufacturing Platform Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cell Therapy GMP Manufacturing Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell Therapy GMP Manufacturing Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell Therapy GMP Manufacturing Platform market include Cellares, Miltenyi Biotec, Cytiva, Lonza, Adva Biotechnology, BioNTech, 3M, Ori Biotech and Limula, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell Therapy GMP Manufacturing Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Therapy GMP Manufacturing Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Therapy GMP Manufacturing Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Therapy GMP Manufacturing Platform market.

Cell Therapy GMP Manufacturing Platform Segment by Company

Cellares

Miltenyi Biotec

Cytiva

Lonza

Adva Biotechnology

BioNTech

3M

Ori Biotech

Limula

Resilience

Cellistic

Catalent

Criver

ElevateBio

Ultragenyx

Cell Therapy GMP Manufacturing Platform Segment by Type

Autologous Cell Therapy GMP Manufacturing Platform

Allogeneic Cell Therapy GMP Manufacturing Platform

Cell Therapy GMP Manufacturing Platform Segment by Application

Clinical Research

Commercial Production

Cell Therapy GMP Manufacturing Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell Therapy GMP Manufacturing Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell Therapy GMP Manufacturing Platform key companies, revenue, market share, and recent developments.

3. To split the Cell Therapy GMP Manufacturing Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell Therapy GMP Manufacturing Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell Therapy GMP Manufacturing Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Cell Therapy GMP Manufacturing Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy GMP Manufacturing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy GMP Manufacturing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy GMP Manufacturing Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy GMP Manufacturing Platform industry.

Chapter 3: Detailed analysis of Cell Therapy GMP Manufacturing Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell Therapy GMP Manufacturing Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell Therapy GMP Manufacturing Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell Therapy GMP Manufacturing Platform Industry Trends Table 2. Cell Therapy GMP Manufacturing Platform Industry Drivers Table 3. Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges Table 4. Cell Therapy GMP Manufacturing Platform Industry Restraints Table 5. Global Cell Therapy GMP Manufacturing Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell Therapy GMP Manufacturing Platform Revenue Share by Company (2021-2026) Table 7. Global Cell Therapy GMP Manufacturing Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell Therapy GMP Manufacturing Platform Key Company Manufacturing Base & Headquarters Table 9. Global Cell Therapy GMP Manufacturing Platform Company, Product Type & Application Table 10. Global Cell Therapy GMP Manufacturing Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell Therapy GMP Manufacturing Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Autologous Cell Therapy GMP Manufacturing Platform Table 15. Significant Companies of Allogeneic Cell Therapy GMP Manufacturing Platform Table 16. Global Cell Therapy GMP Manufacturing Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cell Therapy GMP Manufacturing Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cell Therapy GMP Manufacturing Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Type (2021-2026) Table 20. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Research Table 22. Significant Companies of Commercial Production Table 23. Global Cell Therapy GMP Manufacturing Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Cell Therapy GMP Manufacturing Platform Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Cell Therapy GMP Manufacturing Platform Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Application (2021-2026) Table 27. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Application (2027-2032) Table 28. Global Cell Therapy GMP Manufacturing Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cell Therapy GMP Manufacturing Platform Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Region (2021-2026) Table 31. Global Cell Therapy GMP Manufacturing Platform Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Region (2027-2032) Table 33. Global Cell Therapy GMP Manufacturing Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cell Therapy GMP Manufacturing Platform Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Cell Therapy GMP Manufacturing Platform Sales Value Market Share by Country (2021-2026) Table 36. Global Cell Therapy GMP Manufacturing Platform Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Cell Therapy GMP Manufacturing Platform Sales Value Market Share by Country (2027-2032) Table 38. Cellares Company Information Table 39. Cellares Business Overview Table 40. Cellares Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio Table 42. Cellares Recent Development Table 43. Miltenyi Biotec Company Information Table 44. Miltenyi Biotec Business Overview Table 45. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio Table 47. Miltenyi Biotec Recent Development Table 48. Cytiva Company Information Table 49. Cytiva Business Overview Table 50. Cytiva Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio Table 52. Cytiva Recent Development Table 53. Lonza Company Information Table 54. Lonza Business Overview Table 55. Lonza Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio Table 57. Lonza Recent Development Table 58. Adva Biotechnology Company Information Table 59. Adva Biotechnology Business Overview Table 60. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio Table 62. Adva Biotechnology Recent Development Table 63. BioNTech Company Information Table 64. BioNTech Business Overview Table 65. BioNTech Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 67. BioNTech Recent Development Table 68. 3M Company Information Table 69. 3M Business Overview Table 70. 3M Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. 3M Cell Therapy GMP Manufacturing Platform Product Portfolio Table 72. 3M Recent Development Table 73. Ori Biotech Company Information Table 74. Ori Biotech Business Overview Table 75. Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 77. Ori Biotech Recent Development Table 78. Limula Company Information Table 79. Limula Business Overview Table 80. Limula Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Limula Cell Therapy GMP Manufacturing Platform Product Portfolio Table 82. Limula Recent Development Table 83. Resilience Company Information Table 84. Resilience Business Overview Table 85. Resilience Cell Therapy GMP Manufacturing Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio Table 87. Resilience Recent Development Table 88. Cellistic Company Information Table 89. Cellistic Business Overview Table 90. Cellistic Cell Therapy GMP Manufacturing Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio Table 92. Cellistic Recent Development Table 93. Catalent Company Information Table 94. Catalent Business Overview Table 95. Catalent Cell Therapy GMP Manufacturing Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio Table 97. Catalent Recent Development Table 98. Criver Company Information Table 99. Criver Business Overview Table 100. Criver Cell Therapy GMP Manufacturing Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Criver Cell Therapy GMP Manufacturing Platform Product Portfolio Table 102. Criver Recent Development Table 103. ElevateBio Company Information Table 104. ElevateBio Business Overview Table 105. ElevateBio Cell Therapy GMP Manufacturing Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio Table 107. ElevateBio Recent Development Table 108. Ultragenyx Company Information Table 109. Ultragenyx Business Overview Table 110. Ultragenyx Cell Therapy GMP Manufacturing Platform Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio Table 112. Ultragenyx Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Cell Therapy GMP Manufacturing Platform Product Image Figure 2. Global Cell Therapy GMP Manufacturing Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Therapy GMP Manufacturing Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell Therapy GMP Manufacturing Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Autologous Cell Therapy GMP Manufacturing Platform Image Figure 8. Allogeneic Cell Therapy GMP Manufacturing Platform Image Figure 9. Global Cell Therapy GMP Manufacturing Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cell Therapy GMP Manufacturing Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Type (2021-2032) Figure 12. Clinical Research Image Figure 13. Commercial Production Image Figure 14. Global Cell Therapy GMP Manufacturing Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cell Therapy GMP Manufacturing Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Application (2021-2032) Figure 17. Global Cell Therapy GMP Manufacturing Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032) & (US$ Million) Figure 20. North America Cell Therapy GMP Manufacturing Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Cell Therapy GMP Manufacturing Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Cell Therapy GMP Manufacturing Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032) & (US$ Million) Figure 26. South America Cell Therapy GMP Manufacturing Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Cell Therapy GMP Manufacturing Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy GMP Manufacturing Platform
  • Allogeneic Cell Therapy GMP Manufacturing Platform
Applications
  • Clinical Research
  • Commercial Production
Companies covered
  • Cellares
  • Miltenyi Biotec
  • Cytiva
  • Lonza
  • Adva Biotechnology
  • BioNTech
  • 3M
  • Ori Biotech
  • Limula
  • Resilience
  • Cellistic
  • Catalent
  • Criver
  • ElevateBio
  • Ultragenyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell Therapy GMP Manufacturing Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell Therapy GMP Manufacturing Platform Market Dynamics
  1. 2.1 Cell Therapy GMP Manufacturing Platform Industry Trends
  2. 2.2 Cell Therapy GMP Manufacturing Platform Industry Drivers
  3. 2.3 Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges
  4. 2.4 Cell Therapy GMP Manufacturing Platform Industry Restraints
3 Cell Therapy GMP Manufacturing Platform Market by Company
  1. 3.1 Global Cell Therapy GMP Manufacturing Platform Company Revenue Ranking in 2025
  2. 3.2 Global Cell Therapy GMP Manufacturing Platform Revenue by Company (2021-2026)
  3. 3.3 Global Cell Therapy GMP Manufacturing Platform Company Ranking (2024-2026)
  4. 3.4 Global Cell Therapy GMP Manufacturing Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell Therapy GMP Manufacturing Platform Company Product Type and Application
  6. 3.6 Global Cell Therapy GMP Manufacturing Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell Therapy GMP Manufacturing Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell Therapy GMP Manufacturing Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell Therapy GMP Manufacturing Platform Market by Type
  1. 4.1 Cell Therapy GMP Manufacturing Platform Type Introduction
  2. 4.1.1 Autologous Cell Therapy GMP Manufacturing Platform
  3. 4.1.2 Allogeneic Cell Therapy GMP Manufacturing Platform
  4. 4.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Type
  5. 4.2.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Type (2021-2032)
5 Cell Therapy GMP Manufacturing Platform Market by Application
  1. 5.1 Cell Therapy GMP Manufacturing Platform Application Introduction
  2. 5.1.1 Clinical Research
  3. 5.1.2 Commercial Production
  4. 5.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Application
  5. 5.2.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cell Therapy GMP Manufacturing Platform Sales Value Share by Application (2021-2032)
6 Cell Therapy GMP Manufacturing Platform Regional Value Analysis
  1. 6.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032)
  7. 6.3.2 North America Cell Therapy GMP Manufacturing Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Cell Therapy GMP Manufacturing Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell Therapy GMP Manufacturing Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032)
  16. 6.6.2 South America Cell Therapy GMP Manufacturing Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell Therapy GMP Manufacturing Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell Therapy GMP Manufacturing Platform Sales Value Share by Country, 2025 VS 2032
7 Cell Therapy GMP Manufacturing Platform Country-level Value Analysis
  1. 7.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell Therapy GMP Manufacturing Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell Therapy GMP Manufacturing Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell Therapy GMP Manufacturing Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell Therapy GMP Manufacturing Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell Therapy GMP Manufacturing Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cellares
  2. 8.1.1 Cellares Company Information
  3. 8.1.2 Cellares Business Overview
  4. 8.1.3 Cellares Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio
  6. 8.1.5 Cellares Recent Developments
  7. 8.2 Miltenyi Biotec
  8. 8.2.1 Miltenyi Biotec Company Information
  9. 8.2.2 Miltenyi Biotec Business Overview
  10. 8.2.3 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio
  12. 8.2.5 Miltenyi Biotec Recent Developments
  13. 8.3 Cytiva
  14. 8.3.1 Cytiva Company Information
  15. 8.3.2 Cytiva Business Overview
  16. 8.3.3 Cytiva Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio
  18. 8.3.5 Cytiva Recent Developments
  19. 8.4 Lonza
  20. 8.4.1 Lonza Company Information
  21. 8.4.2 Lonza Business Overview
  22. 8.4.3 Lonza Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio
  24. 8.4.5 Lonza Recent Developments
  25. 8.5 Adva Biotechnology
  26. 8.5.1 Adva Biotechnology Company Information
  27. 8.5.2 Adva Biotechnology Business Overview
  28. 8.5.3 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio
  30. 8.5.5 Adva Biotechnology Recent Developments
  31. 8.6 BioNTech
  32. 8.6.1 BioNTech Company Information
  33. 8.6.2 BioNTech Business Overview
  34. 8.6.3 BioNTech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio
  36. 8.6.5 BioNTech Recent Developments
  37. 8.7 3M
  38. 8.7.1 3M Company Information
  39. 8.7.2 3M Business Overview
  40. 8.7.3 3M Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 3M Cell Therapy GMP Manufacturing Platform Product Portfolio
  42. 8.7.5 3M Recent Developments
  43. 8.8 Ori Biotech
  44. 8.8.1 Ori Biotech Company Information
  45. 8.8.2 Ori Biotech Business Overview
  46. 8.8.3 Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio
  48. 8.8.5 Ori Biotech Recent Developments
  49. 8.9 Limula
  50. 8.9.1 Limula Company Information
  51. 8.9.2 Limula Business Overview
  52. 8.9.3 Limula Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Limula Cell Therapy GMP Manufacturing Platform Product Portfolio
  54. 8.9.5 Limula Recent Developments
  55. 8.10 Resilience
  56. 8.10.1 Resilience Company Information
  57. 8.10.2 Resilience Business Overview
  58. 8.10.3 Resilience Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio
  60. 8.10.5 Resilience Recent Developments
  61. 8.11 Cellistic
  62. 8.11.1 Cellistic Company Information
  63. 8.11.2 Cellistic Business Overview
  64. 8.11.3 Cellistic Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio
  66. 8.11.5 Cellistic Recent Developments
  67. 8.12 Catalent
  68. 8.12.1 Catalent Company Information
  69. 8.12.2 Catalent Business Overview
  70. 8.12.3 Catalent Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio
  72. 8.12.5 Catalent Recent Developments
  73. 8.13 Criver
  74. 8.13.1 Criver Company Information
  75. 8.13.2 Criver Business Overview
  76. 8.13.3 Criver Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Criver Cell Therapy GMP Manufacturing Platform Product Portfolio
  78. 8.13.5 Criver Recent Developments
  79. 8.14 ElevateBio
  80. 8.14.1 ElevateBio Company Information
  81. 8.14.2 ElevateBio Business Overview
  82. 8.14.3 ElevateBio Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio
  84. 8.14.5 ElevateBio Recent Developments
  85. 8.15 Ultragenyx
  86. 8.15.1 Ultragenyx Company Information
  87. 8.15.2 Ultragenyx Business Overview
  88. 8.15.3 Ultragenyx Cell Therapy GMP Manufacturing Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio
  90. 8.15.5 Ultragenyx Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst